숙주 세포 오염물질 검사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Host Cell Contaminant Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 6,879,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,046,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,699,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

주요 인사이트

• 숙주 세포 오염물질 검사 시장 규모(2024년) : 3억 2,830만 달러
• 시장 규모 예측(2031년) : 4억 7,880만 달러
• 세계 시장 성장률(2024-2031년) : CAGR 5.5%

시장 촉진요인:

효율적인 숙주 세포 오염물질 검사에 대한 수요는 주로 바이오의약품의 품질 보증에 대한 요구가 증가함에 따라 발생합니다. 업계가 지속적으로 성장함에 따라 제품의 안전성, 유효성 및 규제 준수 보장에 대한 중요성이 커지고 있습니다. 차세대 시퀀싱 및 고해상도 질량 분석과 같은 검출 기술의 발전은 정확하고 신뢰할 수 있는 결과를 제공함으로써 시장 성장을 더욱 촉진하고 있습니다. 또한, 만성질환의 증가와 바이오시밀러 개발의 증가로 인해 엄격한 오염물질 검사 프로토콜의 중요성이 증가하고 있습니다.

시장 억제요인:

유망한 성장 전망에도 불구하고, 시장은 여전히 도전에 직면해 있습니다. 특히 중소기업과 학술 기관은 고급 테스트 및 장비와 관련된 높은 비용으로 인해 장벽이 될 수 있습니다. 또한, 테스트 프로토콜이 지역별로 표준화되지 않아 일관성이 없어 세계 컴플라이언스 노력에 영향을 미칠 수 있습니다. 이러한 요인들은 특히 비용 효율성이 중요한 신흥국에서 시장 확대를 제한할 수 있습니다.

시장 기회:

이 시장에는 특히 오염물질 검사 프로세스에서 자동화와 AI를 통합하는 데 있어 큰 비즈니스 기회가 있습니다. 자동화 시스템은 처리량을 향상시킬 뿐만 아니라 인적 오류를 최소화하고 더 높은 정확도를 보장합니다. 바이오 제약사와 위탁 개발 기관 간의 협업은 효율적인 자원 활용과 전문 지식 공유를 가능하게 하며 또 다른 성장의 길을 제시하고 있습니다. 또한, 세계 규제 강화로 인해 보다 진보되고 종합적인 검사 솔루션의 채택이 가속화될 것으로 예상됩니다.

세계의 숙주 세포 오염물질 검사 시장을 조사했으며, 시장의 정의와 개요, 시장 촉진·억제요인, 각종 동향, 시장 기회와 과제, 시장 규모(금액, 일부 수량) 추이와 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의
• 시장 분류

제3장 숙주 세포 오염물질 검사 : 시장 기회 분석

• 거시경제 요인
• 기회 분석
• 시장 역학

제4장 북미의 숙주 세포 오염물질 검사 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 미국
  • 캐나다
• 시장 규모 추정과 예측 : 제품 유형별
  • PCR 기반 어세이
  • ELISA 기반 어세이
• 시장 규모 추정과 예측 : 플랫폼별
  • 미생물
  • 포유류
  • 기타
• 시장 규모 추정과 예측 : 용도별
  • 연구개발
  • 임상 응용
• 시장 규모 추정과 예측 : 최종사용자별
  • 바이오의약품 기업
  • CRO
  • CMO
  • 학술 및 연구기관
• 성장 촉진요인·억제요인 : 영향 분석
• 시장 매력 분석
• 주요 진출 기업
• 시장 입지(강도 맵)

제5장 라틴아메리카의 숙주 세포 오염물질 검사 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 브라질
  • 멕시코
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 플랫폼별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 최종사용자별
• 성장 촉진요인·억제요인 : 영향 분석
• 시장 매력 분석
• 주요 진출 기업
• 시장 입지(강도 맵)

제6장 유럽의 숙주 세포 오염물질 검사 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 러시아
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 플랫폼별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 최종사용자별
• 성장 촉진요인·억제요인 : 영향 분석
• 시장 매력 분석
• 주요 진출 기업
• 시장 입지(강도 맵)

제7장 아시아태평양의 숙주 세포 오염물질 검사 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • 중국
  • 일본
  • 인도
  • ASEAN
  • 호주·뉴질랜드
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 플랫폼별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 최종사용자별
• 성장 촉진요인·억제요인 : 영향 분석
• 시장 매력 분석
• 주요 진출 기업
• 시장 입지(강도 맵)

제8장 중동 및 아프리카의 숙주 세포 오염물질 검사 시장 분석과 예측

• 시장 규모 추정과 예측 : 국가별
  • GCC 국가
  • 남아프리카공화국
  • 북아프리카
  • 기타
• 시장 규모 추정과 예측 : 제품 유형별
• 시장 규모 추정과 예측 : 플랫폼별
• 시장 규모 추정과 예측 : 용도별
• 시장 규모 추정과 예측 : 최종사용자별
• 성장 촉진요인·억제요인 : 영향 분석
• 시장 매력 분석
• 주요 진출 기업
• 시장 입지(강도 맵)

제9장 예측요인 : 관련성과 영향

제10장 예측 가정

제11장 경쟁 구도

• 경쟁 대시보드
• 기업 개요(상세 : 개요, 재무, 전략, SWOT, 최근 동향)
  • BioGenes GmbH
  • Bio-Rad Laboratories, Inc.
  • Cisbio Bioassays
  • Cygnus Technologies LLC(A Maravai Lifesciences Company)
  • Enzo Life Sciences, Inc.
  • ForteBio(A Pall Company)
  • GE Healthcare Life Sciences
  • Molecular Devices LLC
  • ProteinSimple(A BioTechne Brand)
  • Thermo Fisher Scientific, Inc.

제12장 세계의 숙주 세포 오염물질 검사 시장 분석과 예측 : 지역별

제13장 세계의 숙주 세포 오염물질 검사 시장 분석과 예측 : 제품 유형별

제14장 세계의 숙주 세포 오염물질 검사 시장 분석과 예측 : 플랫폼별

제15장 세계의 숙주 세포 오염물질 검사 시장 분석과 예측 : 용도별

제16장 세계의 숙주 세포 오염물질 검사 시장 분석과 예측 : 최종사용자별

제17장 세계의 숙주 세포 오염물질 검사 시장 분석과 예측

• 시장 규모·전년비 성장률
• 수익 기회

제18장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global host cell contaminant testing market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Host Cell Contaminant Testing Market Size (2024E): US$ 328.3 Mn
• Projected Market Value (2031F): US$ 478.8 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 5.5%

Host Cell Contaminant Testing Market - Report Scope:

Host cell proteins refer to a diverse group of proteins derived from host cells such as yeast, E. coli, and mammals. These proteins exhibit significant differences in properties, isoelectric points, and molecular masses. The identification and quantification of host cell contaminants are crucial during biopharmaceutical development. A wide array of techniques, including immuno-specific methods like ELISA, Western Blot, and PCR, as well as non-specific methods like electrophoresis and LC-MS, are utilized to ensure the purity of biopharmaceutical samples. The ideal approach combines high throughput and quantitative analysis to identify all types of contaminants effectively.

Market Drivers:

The demand for efficient host cell contaminant testing methods is primarily driven by the growing need for quality assurance in biopharmaceuticals. As the industry continues to expand, there is a heightened emphasis on ensuring the safety, efficacy, and regulatory compliance of products. Advances in detection technologies, such as next-generation sequencing and high-resolution mass spectrometry, further propel market growth by offering precise and reliable results. Additionally, the increasing prevalence of chronic diseases and the rise in biosimilar development are amplifying the importance of rigorous contaminant testing protocols.

Market Restraints:

Despite the promising growth prospects, the market faces certain challenges. High costs associated with advanced testing methods and equipment can act as barriers, especially for smaller companies and academic institutions. Furthermore, the lack of standardization in testing protocols across regions leads to inconsistencies, impacting global compliance efforts. These factors can limit market expansion, particularly in emerging economies where cost-effectiveness is a critical consideration.

Market Opportunities:

The market holds significant opportunities, particularly in the integration of automation and artificial intelligence in contaminant testing processes. Automated systems not only enhance throughput but also minimize human error, ensuring higher accuracy. Collaborations between biopharmaceutical companies and contract research organizations present another growth avenue, enabling efficient resource utilization and expertise sharing. Furthermore, increasing regulatory stringency worldwide is likely to drive the adoption of more advanced and comprehensive testing solutions.

Competitive Intelligence and Business Strategy:

The global host cell contaminant testing market is characterized by the presence of key players focusing on innovation, strategic collaborations, and geographic expansion. Leading companies are investing in research and development to offer cutting-edge solutions, ensuring precision and efficiency in contaminant detection. Partnerships between large-scale pharmaceutical firms and smaller biopharmaceutical entities are fostering market growth, enabling the introduction of novel testing methodologies.

.

Key Companies Profiled:

• BioGenes GmbH
• Bio-Rad Laboratories, Inc.
• Cisbio Bioassays
• Cygnus Technologies LLC (A Maravai Lifesciences Company)
• Enzo Life Sciences, Inc.
• ForteBio (A Pall Company)
• GE Healthcare Life Sciences
• Molecular Devices LLC
• ProteinSimple (A BioTechne Brand)
• Thermo Fisher Scientific, Inc.
• Others

Host Cell Contaminant Testing Market Segmentation:

By Product Type:

• PCR-based Assays
• ELISA-based Assays

By Platform:

• Microbial
• Mammalian
• Others

By Application:

• Research & Development
• Clinical Applications

By End User:

• Biopharmaceutical Companies
• Contract Research Organizations
• Contract Manufacturing Organizations
• Academic & Research Institutes

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy

3. Host Cell Contaminant Testing Market Opportunity Analysis

• 3.1. Macro-Economic Factors
• 3.2. Opportunity Analysis
• 3.3. Market Dynamics

4. North America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 4.1. Introduction
• 4.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
  • 4.2.1. U.S.
  • 4.2.2. Canada
• 4.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
  • 4.3.1. U.S.
  • 4.3.2. Canada
• 4.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
  • 4.4.1. PCR-based Assays
  • 4.4.2. ELISA-based Assays
• 4.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
  • 4.5.1. PCR-based Assays
  • 4.5.2. ELISA-based Assays
• 4.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
  • 4.6.1. Microbial
  • 4.6.2. Mammalian
  • 4.6.3. Others
• 4.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
  • 4.7.1. Microbial
  • 4.7.2. Mammalian
  • 4.7.3. Others
• 4.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
  • 4.8.1. Research & Development
  • 4.8.2. Clinical Applications
• 4.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
  • 4.9.1. Research & Development
  • 4.9.2. Clinical Applications
• 4.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
  • 4.10.1. Biopharmaceutical Companies
  • 4.10.2. Contract Research Organizations
  • 4.10.3. Contract Manufacturing Organizations
  • 4.10.4. Academic & Research Institutes
• 4.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
  • 4.11.1. Biopharmaceutical Companies
  • 4.11.2. Contract Research Organizations
  • 4.11.3. Contract Manufacturing Organizations
  • 4.11.4. Academic & Research Institutes
• 4.12. Drivers and Restraints: Impact Analysis
• 4.13. Market Attractiveness Analysis
  • 4.13.1. By Country
  • 4.13.2. By Product Type
  • 4.13.3. By Platform
  • 4.13.4. By Application
  • 4.13.5. By End User
• 4.14. Key Representative Market Participants
• 4.15. Market Presence (Intensity Map)

5. Latin America Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 5.1. Introduction
• 5.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
  • 5.2.1. Brazil
  • 5.2.2. Mexico
  • 5.2.3. Rest of Latin America
• 5.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
  • 5.3.1. Brazil
  • 5.3.2. Mexico
  • 5.3.3. Rest of Latin America
• 5.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
  • 5.4.1. PCR-based Assays
  • 5.4.2. ELISA-based Assays
• 5.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
  • 5.5.1. PCR-based Assays
  • 5.5.2. ELISA-based Assays
• 5.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
  • 5.6.1. Microbial
  • 5.6.2. Mammalian
  • 5.6.3. Others
• 5.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
  • 5.7.1. Microbial
  • 5.7.2. Mammalian
  • 5.7.3. Others
• 5.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
  • 5.8.1. Research & Development
  • 5.8.2. Clinical Applications
• 5.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
  • 5.9.1. Research & Development
  • 5.9.2. Clinical Applications
• 5.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
  • 5.10.1. Biopharmaceutical Companies
  • 5.10.2. Contract Research Organizations
  • 5.10.3. Contract Manufacturing Organizations
  • 5.10.4. Academic & Research Institutes
• 5.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
  • 5.11.1. Biopharmaceutical Companies
  • 5.11.2. Contract Research Organizations
  • 5.11.3. Contract Manufacturing Organizations
  • 5.11.4. Academic & Research Institutes
• 5.12. Drivers and Restraints: Impact Analysis
• 5.13. Market Attractiveness Analysis
  • 5.13.1. By Country
  • 5.13.2. By Product Type
  • 5.13.3. By Platform
  • 5.13.4. By Application
  • 5.13.5. By End User
• 5.14. Key Representative Market Participants
• 5.15. Market Presence (Intensity Map)

6. Europe Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 6.1. Introduction
• 6.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
  • 6.2.1. Germany
  • 6.2.2. U.K.
  • 6.2.3. France
  • 6.2.4. Italy
  • 6.2.5. Spain
  • 6.2.6. Russia
  • 6.2.7. Rest of Europe
• 6.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
  • 6.3.1. Germany
  • 6.3.2. U.K.
  • 6.3.3. France
  • 6.3.4. Italy
  • 6.3.5. Spain
  • 6.3.6. Russia
  • 6.3.7. Rest of Europe
• 6.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
  • 6.4.1. PCR-based Assays
  • 6.4.2. ELISA-based Assays
• 6.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
  • 6.5.1. PCR-based Assays
  • 6.5.2. ELISA-based Assays
• 6.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
  • 6.6.1. Microbial
  • 6.6.2. Mammalian
  • 6.6.3. Others
• 6.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
  • 6.7.1. Microbial
  • 6.7.2. Mammalian
  • 6.7.3. Others
• 6.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
  • 6.8.1. Research & Development
  • 6.8.2. Clinical Applications
• 6.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
  • 6.9.1. Research & Development
  • 6.9.2. Clinical Applications
• 6.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
  • 6.10.1. Biopharmaceutical Companies
  • 6.10.2. Contract Research Organizations
  • 6.10.3. Contract Manufacturing Organizations
  • 6.10.4. Academic & Research Institutes
• 6.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
  • 6.11.1. Biopharmaceutical Companies
  • 6.11.2. Contract Research Organizations
  • 6.11.3. Contract Manufacturing Organizations
  • 6.11.4. Academic & Research Institutes
• 6.12. Drivers and Restraints: Impact Analysis
• 6.13. Market Attractiveness Analysis
  • 6.13.1. By Country
  • 6.13.2. By Product Type
  • 6.13.3. By Platform
  • 6.13.4. By Application
  • 6.13.5. By End User
• 6.14. Key Representative Market Participants
• 6.15. Market Presence (Intensity Map)

7. Asia Pacific Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 7.1. Introduction
• 7.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
  • 7.2.1. China
  • 7.2.2. Japan
  • 7.2.3. India
  • 7.2.4. ASEAN
  • 7.2.5. Australia and New Zealand
  • 7.2.6. Rest of Asia Pacific
• 7.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
  • 7.3.1. China
  • 7.3.2. Japan
  • 7.3.3. India
  • 7.3.4. ASEAN
  • 7.3.5. Australia and New Zealand
  • 7.3.6. Rest of Asia Pacific
• 7.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
  • 7.4.1. PCR-based Assays
  • 7.4.2. ELISA-based Assays
• 7.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
  • 7.5.1. PCR-based Assays
  • 7.5.2. ELISA-based Assays
• 7.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
  • 7.6.1. Microbial
  • 7.6.2. Mammalian
  • 7.6.3. Others
• 7.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
  • 7.7.1. Microbial
  • 7.7.2. Mammalian
  • 7.7.3. Others
• 7.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
  • 7.8.1. Research & Development
  • 7.8.2. Clinical Applications
• 7.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
  • 7.9.1. Research & Development
  • 7.9.2. Clinical Applications
• 7.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
  • 7.10.1. Biopharmaceutical Companies
  • 7.10.2. Contract Research Organizations
  • 7.10.3. Contract Manufacturing Organizations
  • 7.10.4. Academic & Research Institutes
• 7.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
  • 7.11.1. Biopharmaceutical Companies
  • 7.11.2. Contract Research Organizations
  • 7.11.3. Contract Manufacturing Organizations
  • 7.11.4. Academic & Research Institutes
• 7.12. Drivers and Restraints: Impact Analysis
• 7.13. Market Attractiveness Analysis
  • 7.13.1. By Country
  • 7.13.2. By Product Type
  • 7.13.3. By Platform
  • 7.13.4. By Application
  • 7.13.5. By End User
• 7.14. Key Representative Market Participants
• 7.15. Market Presence (Intensity Map)

8. Middle East & Africa Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 8.1. Introduction
• 8.2. Historical Market Size (US$ Mn ) Trend Analysis By Country, 2019 - 2023
  • 8.2.1. GCC Countries
  • 8.2.2. South Africa
  • 8.2.3. North Africa
  • 8.2.4. Rest of MEA
• 8.3. Market Size (US$ Mn ) Forecast By Country, 2024 - 2031
  • 8.3.1. GCC Countries
  • 8.3.2. South Africa
  • 8.3.3. North Africa
  • 8.3.4. Rest of MEA
• 8.4. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
  • 8.4.1. PCR-based Assays
  • 8.4.2. ELISA-based Assays
• 8.5. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
  • 8.5.1. PCR-based Assays
  • 8.5.2. ELISA-based Assays
• 8.6. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
  • 8.6.1. Microbial
  • 8.6.2. Mammalian
  • 8.6.3. Others
• 8.7. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
  • 8.7.1. Microbial
  • 8.7.2. Mammalian
  • 8.7.3. Others
• 8.8. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
  • 8.8.1. Research & Development
  • 8.8.2. Clinical Applications
• 8.9. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
  • 8.9.1. Research & Development
  • 8.9.2. Clinical Applications
• 8.10. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
  • 8.10.1. Biopharmaceutical Companies
  • 8.10.2. Contract Research Organizations
  • 8.10.3. Contract Manufacturing Organizations
  • 8.10.4. Academic & Research Institutes
• 8.11. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
  • 8.11.1. Biopharmaceutical Companies
  • 8.11.2. Contract Research Organizations
  • 8.11.3. Contract Manufacturing Organizations
  • 8.11.4. Academic & Research Institutes
• 8.12. Drivers and Restraints: Impact Analysis
• 8.13. Market Attractiveness Analysis
  • 8.13.1. By Country
  • 8.13.2. By Product Type
  • 8.13.3. By Platform
  • 8.13.4. By Application
  • 8.13.5. By End User
• 8.14. Key Representative Market Participants
• 8.15. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape

• 11.1. Competition Dashboard
• 11.2. Company Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
  • 11.2.1. BioGenes GmbH
  • 11.2.2. Bio-Rad Laboratories, Inc.
  • 11.2.3. Cisbio Bioassays
  • 11.2.4. Cygnus Technologies LLC (A Maravai Lifesciences Company)
  • 11.2.5. Enzo Life Sciences, Inc.
  • 11.2.6. ForteBio (A Pall Company)
  • 11.2.7. GE Healthcare Life Sciences
  • 11.2.8. Molecular Devices LLC
  • 11.2.9. ProteinSimple (A BioTechne Brand)
  • 11.2.10. Thermo Fisher Scientific, Inc.

12. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

• 12.1. Introduction/Key Findings
• 12.2. Historical Market Size (US$ Mn ) Trend Analysis By Region, 2019 - 2023
  • 12.2.1. North America
  • 12.2.2. Latin America
  • 12.2.3. Europe
  • 12.2.4. Asia Pacific
  • 12.2.5. Middle East & Africa
• 12.3. Market Size (US$ Mn ) Forecast By Region, 2024 - 2031
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. Asia Pacific
  • 12.3.5. Middle East & Africa
• 12.4. Market Attractiveness Analysis By Region

13. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

• 13.1. Introduction/Key Findings
• 13.2. Historical Market Size (US$ Mn ) Trend Analysis By Product Type, 2019 - 2023
  • 13.2.1. PCR-based Assays
  • 13.2.2. ELISA-based Assays
• 13.3. Market Size (US$ Mn ) Forecast By Product Type, 2024 - 2031
  • 13.3.1. PCR-based Assays
  • 13.3.2. ELISA-based Assays
• 13.4. Market Attractiveness Analysis By Product Type

14. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Platform

• 14.1. Introduction/Key Findings
• 14.2. Historical Market Size (US$ Mn ) Trend Analysis By Platform, 2019 - 2023
  • 14.2.1. Microbial
  • 14.2.2. Mammalian
  • 14.2.3. Others
• 14.3. Market Size (US$ Mn ) Forecast By Platform, 2024 - 2031
  • 14.3.1. Microbial
  • 14.3.2. Mammalian
  • 14.3.3. Others
• 14.4. Market Attractiveness Analysis By Platform

15. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

• 15.1. Introduction/Key Findings
• 15.2. Historical Market Size (US$ Mn ) Trend Analysis By Application, 2019 - 2023
  • 15.2.1. Research & Development
  • 15.2.2. Clinical Applications
• 15.3. Market Size (US$ Mn ) Forecast By Application, 2024 - 2031
  • 15.3.1. Research & Development
  • 15.3.2. Clinical Applications
• 15.4. Market Attractiveness Analysis By Application

16. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

• 16.1.Introduction/Key Findings
• 16.2. Historical Market Size (US$ Mn ) Trend Analysis By End User, 2019 - 2023
  • 16.2.1. Biopharmaceutical Companies
  • 16.2.2. Contract Research Organizations
  • 16.2.3. Contract Manufacturing Organizations
  • 16.2.4. Academic & Research Institutes
• 16.3. Market Size (US$ Mn ) Forecast By End User, 2024 - 2031
  • 16.3.1. Biopharmaceutical Companies
  • 16.3.2. Contract Research Organizations
  • 16.3.3. Contract Manufacturing Organizations
  • 16.3.4. Academic & Research Institutes
• 16.4. Market Attractiveness Analysis By End User

17. Global Host Cell Contaminant Testing Market Analysis 2019 - 2023 and Forecast 2024 - 2031

• 17.1. Market Size and Y-o-Y Growth
• 17.2. Absolute $ Opportunity

18. Research Methodology

관련자료